# Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

> **NCT01223131** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 162 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin glargine (HOE901)
- **DRUG:** NPH insulin

## Key facts

- **NCT ID:** NCT01223131
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2014-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01223131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01223131, "Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01223131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*